HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karolyn A Oetjen Selected Research

Karolyn A Oetjen Research Topics

Disease

3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2017
3Leukemia
01/2022 - 01/2017
2Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2017
2Neoplasms (Cancer)
01/2017 - 02/2009
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2022
1Primary Myelofibrosis (Myelosclerosis)
01/2022
1Trichothiodystrophy Syndromes
01/2019
1Neutropenia
01/2017
1Infections
01/2017
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2009
1Necrosis
04/2009

Drug/Important Bio-Agent (IBA)

1RNA (Ribonucleic Acid)IBA
10/2022
1pembrolizumabIBA
01/2022
1DecitabineFDA Link
01/2022
1Therapeutic UsesIBA
01/2022
1JNK Mitogen-Activated Protein KinasesIBA
01/2022
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1LigandsIBA
01/2019
1AntigensIBA
01/2017
1Immune Checkpoint InhibitorsIBA
01/2017
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
04/2009

Therapy/Procedure

3Therapeutics
01/2022 - 02/2009
1Cell Transplantation
01/2022
1Precision Medicine
01/2021
1Homologous Transplantation
01/2017
1Consolidation Chemotherapy
01/2017
1Hematopoietic Stem Cell Transplantation
01/2017
1Drug Therapy (Chemotherapy)
01/2017
1Induction Chemotherapy
01/2017